Items per page
Sort by

Send to:

Choose Destination

Results: 7


Exposure to arginine analog canavanine induces aberrant mitochondrial translation products, mitoribosome stalling, and instability of the mitochondrial proteome.

Konovalova S, Hilander T, Loayza-Puch F, Rooijers K, Agami R, Tyynismaa H.

Int J Biochem Cell Biol. 2015 Jun 25;65:268-274. doi: 10.1016/j.biocel.2015.06.018. [Epub ahead of print]


Ribosome profiling reveals features of normal and disease-associated mitochondrial translation.

Rooijers K, Loayza-Puch F, Nijtmans LG, Agami R.

Nat Commun. 2013;4:2886. doi: 10.1038/ncomms3886.


Lncing protein translation to metastasis.

Loayza-Puch F, Agami R.

EMBO J. 2013 Oct 16;32(20):2657-8. doi: 10.1038/emboj.2013.210. Epub 2013 Sep 24. No abstract available.


p53 induces transcriptional and translational programs to suppress cell proliferation and growth.

Loayza-Puch F, Drost J, Rooijers K, Lopes R, Elkon R, Agami R.

Genome Biol. 2013 Apr 17;14(4):R32. doi: 10.1186/gb-2013-14-4-r32.


The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.

Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kühn U, Menzies FM, Oude Vrielink JA, Bos AJ, Drost J, Rooijers K, Rubinsztein DC, Agami R.

Cell. 2012 Apr 27;149(3):538-53. doi: 10.1016/j.cell.2012.03.022. Epub 2012 Apr 12.


3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene.

Gomez-Benito M, Loayza-Puch F, Oude Vrielink JA, Odero MD, Agami R.

PLoS One. 2011;6(10):e25449. doi: 10.1371/journal.pone.0025449. Epub 2011 Oct 5. Erratum in: PLoS One. 2011;6(11). doi:10.1371/annotation/d39cb963-9277-462f-8070-6409d6fcf484. Oude Vrielink, Joachim [corrected to Oude Vrielink, Joachim A F].


Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs.

Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M.

Oncogene. 2010 May 6;29(18):2638-48. doi: 10.1038/onc.2010.23. Epub 2010 Feb 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk